Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lansang Ez"'
Publikováno v:
Open Access Journal of Clinical Trials, Vol 2014, Iss default, Pp 75-84 (2014)
Shourav Yathindranath,1 Amar Kureishi,2 Simranjit Singh,3 Spencer Yeow,3 Grace Geng,4 Karen Wai,1 Audrey Ho,1 Elvira Zenaida Lansang,1 Ken J Lee5 1Feasibility and Site Identification Asia, 2Drug Development Asia, 3Strategic Planning Asia, Quintiles E
Externí odkaz:
https://doaj.org/article/1fb14c2e3f934622b46c336a122996f1
Publikováno v:
Open Access Journal of Clinical Trials, Vol 2014, Iss default, Pp 1-9 (2013)
David Horsburgh,1 Yi-Chen Josey Lee,2 Elvira Zenaida Lansang,1 Ken J Lee,3 Malcolm Ogg,4 Karen Wai1 1Feasibility and Site Identification Asia, Quintiles East Asia Pte Ltd, Singapore; 2Feasibility and Site Identification Asia, Quintiles East Asia Pte
Externí odkaz:
https://doaj.org/article/644beb73234f4241aa43a37bb3161a96
Publikováno v:
Pediatric Health, Medicine and Therapeutics, Vol 2013, Iss default, Pp 47-54 (2013)
Lisa Marie Saldanha,1 Saumya Nayak,1 Adeline Sng,1 Mei-Ling Long,1 Elisabeth Schrader,2 Amanur Rahman,3 Elvira Zenaida Lansang,1 Karen Wai,1 Ken Lee41Feasibility and Site Identification Asia, Quintiles East Asia Private Limited, Singapore; 2Quintiles
Externí odkaz:
https://doaj.org/article/337063f5c7b44df094adc2fb9688ff17
Publikováno v:
Open Access Journal of Clinical Trials, Vol 2013, Iss default, Pp 33-38 (2013)
Karen Wai,1 Lisa Marie Saldanha,1 Elvira Zenaida Lansang,1 Saumya Nayak,1 Anish Sule,2 Ken J Lee31Feasibility and Site Identification Asia, Quintiles East Asia Pte Ltd, Singapore; 2Feasibility and Site Identification India, Quintiles India, Mumbai, I
Externí odkaz:
https://doaj.org/article/2ea8e2c8df5f45058488e41e5584bf0b
Publikováno v:
Vaccine : Development and Therapy, Vol 2013, Iss default, Pp 1-9 (2013)
Elvira Zenaida Lansang,1 Kenneth Tan,2 Saumya Nayak,1 Ken J Lee,1 Karen Wai1 1Feasibility and Site Identification – Asia, Quintiles East Asia Pte Ltd, Singapore; 2National University of Singapore, Singapore Introduction: Conducting clinical trial f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::f7118790b1f39f5f17e01055cafea86d
http://www.dovepress.com/key-feasibility-considerations-when-conducting-vaccine-clinical-trials-a12504
http://www.dovepress.com/key-feasibility-considerations-when-conducting-vaccine-clinical-trials-a12504
Publikováno v:
Journal of Diabetes & Metabolism.
Introduction: A patient care pathway is the referral pathway from a patient’s first consult with a healthcare provider to the time they receive the most appropriate treatment for their condition. With the increase in diabetes prevalence, clinical t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::138f2048cf74e219ee5646985db75a96
https://doi.org/10.4172/2155-6156.1000331
https://doi.org/10.4172/2155-6156.1000331